These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 33062704)
41. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics. Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339 [TBL] [Abstract][Full Text] [Related]
42. Identification of key genes in the tumor microenvironment of lung adenocarcinoma. Long W; Li Q; Zhang J; Xie H Med Oncol; 2021 Jun; 38(7):83. PubMed ID: 34117948 [TBL] [Abstract][Full Text] [Related]
43. Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma. Song J; Liang K; Wei T; Li L; Huang Z; Chen G; Mao N; Yang J Comb Chem High Throughput Screen; 2023; 26(12):2226-2237. PubMed ID: 36752296 [TBL] [Abstract][Full Text] [Related]
44. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
45. A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma. Jiang H; Xu S; Chen C BMC Cancer; 2020 Aug; 20(1):782. PubMed ID: 32819300 [TBL] [Abstract][Full Text] [Related]
46. Significance of Hou Y; Tan S; Wang G Genet Test Mol Biomarkers; 2021 May; 25(5):346-354. PubMed ID: 33956533 [No Abstract] [Full Text] [Related]
47. Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma. Li Y; Cai Y; Ji L; Wang B; Shi D; Li X PeerJ; 2024; 12():e17746. PubMed ID: 39071134 [TBL] [Abstract][Full Text] [Related]
48. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma. Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337 [TBL] [Abstract][Full Text] [Related]
49. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
50. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma. Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488 [TBL] [Abstract][Full Text] [Related]
51. Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma. Wang Y; Zhang L; Chen Y; Li M; Ha M; Li S J Clin Lab Anal; 2020 Oct; 34(10):e23450. PubMed ID: 32672359 [TBL] [Abstract][Full Text] [Related]
52. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma. Wang H; Wang X; Xu L; Cao H; Zhang J Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491 [TBL] [Abstract][Full Text] [Related]
53. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis. Dodin Y Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325 [TBL] [Abstract][Full Text] [Related]
54. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162 [TBL] [Abstract][Full Text] [Related]
55. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
56. Identification of a ZC3H12D-regulated competing endogenous RNA network for prognosis of lung adenocarcinoma at single-cell level. Chen W; Guo Z; Wu J; Lin G; Chen S; Lin Q; Yang J; Xu Y; Zeng Y BMC Cancer; 2022 Jan; 22(1):115. PubMed ID: 35090416 [TBL] [Abstract][Full Text] [Related]
57. Identification of differentially expressed genes in lung adenocarcinoma cells using single-cell RNA sequencing not detected using traditional RNA sequencing and microarray. Chen Z; Zhao M; Li M; Sui Q; Bian Y; Liang J; Hu Z; Zheng Y; Lu T; Huang Y; Zhan C; Jiang W; Wang Q; Tan L Lab Invest; 2020 Oct; 100(10):1318-1329. PubMed ID: 32327726 [TBL] [Abstract][Full Text] [Related]
58. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma. Liang X; Chen Y; Fan Y Environ Sci Pollut Res Int; 2022 Mar; 29(15):22012-22030. PubMed ID: 34775559 [TBL] [Abstract][Full Text] [Related]
59. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways. Fei H; Chen S; Xu C J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13. Wang J; Shi W; Miao Y; Gan J; Guan Q; Ran J Bioengineered; 2021 Dec; 12(1):6286-6304. PubMed ID: 34494914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]